Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
bevacizumab (avastin) (2 trials)
durvalumab (imfinzi) (1 trial)
letrozole (femara) (1 trial)
me-344 (1 trial)
nintedanib (ofev) (1 trial)
sodium chloride (1 trial)
Breast Neoplasms (Phase 1)
Carcinoma (Phase 1)
Trials (3 total)
Trial APIs (6 total)